MODEL-AD
@model-ad.bsky.social
Model Organism Development and Evaluation for Late-onset AD. NIA collaborative effort between IU, JAX, UPitt, UCI & Sage Bionetworks to develop new models for LOAD for unrestricted use.
www.model-ad.org
www.model-ad.org
We probably have something for you! www.alzforum.org/news/confere...
MODEL-AD Probably Has Something for You | ALZFORUM
www.alzforum.org
November 18, 2024 at 2:54 PM
We probably have something for you! www.alzforum.org/news/confere...
Reposted by MODEL-AD
AlzForum reports on our latest MODEL-AD efforts to study late-onset Alzheimer's disease in mice starting from genetic and environmental risk factors rather than familial transgenes: #EndALZ @model-ad.bsky.social
Mouse Model LOADs on the Alzheimer’s Risk Factors | ALZFORUM
www.alzforum.org
January 19, 2024 at 4:46 PM
AlzForum reports on our latest MODEL-AD efforts to study late-onset Alzheimer's disease in mice starting from genetic and environmental risk factors rather than familial transgenes: #EndALZ @model-ad.bsky.social
Reposted by MODEL-AD
In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1
In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1
Introduction: Genome-wide association studies have identified over 70 genetic loci associated with l
www.biorxiv.org
December 24, 2023 at 11:16 AM
In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1
Reposted by MODEL-AD
Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1
Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1
INTRODUCTION: Increasing evidence suggests that metabolic impairments contribute to early Alzheimer'
www.biorxiv.org
December 23, 2023 at 3:15 AM
Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1
Reposted by MODEL-AD
Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1
Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1
INTRODUCTION: MODEL-AD is creating and distributing novel mouse models with humanized, clinically re
www.biorxiv.org
December 20, 2023 at 5:16 PM
Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1
Reposted by MODEL-AD
MARMO-AD has arrived on BlueSky! Follow us for research updates and news from the MARMO-AD team.
December 13, 2023 at 4:09 PM
MARMO-AD has arrived on BlueSky! Follow us for research updates and news from the MARMO-AD team.
MODEL-AD has arrived!
Follow us for updates on new mouse models for Alzheimer's research, open data resources from animal models, and where to find us at your favorite conferences. #EndAlz
Follow us for updates on new mouse models for Alzheimer's research, open data resources from animal models, and where to find us at your favorite conferences. #EndAlz
December 6, 2023 at 4:13 PM
MODEL-AD has arrived!
Follow us for updates on new mouse models for Alzheimer's research, open data resources from animal models, and where to find us at your favorite conferences. #EndAlz
Follow us for updates on new mouse models for Alzheimer's research, open data resources from animal models, and where to find us at your favorite conferences. #EndAlz